Pharmaceuticals | Buy Stock In Gw

If you are looking to buy stock in , it is important to know that as of April 28, 2026, the company no longer trades under its own ticker symbol. It was fully acquired by Jazz Pharmaceuticals in May 2021 for approximately $7.2 billion.

Investment Rationale for GW Pharmaceuticals (via Jazz Pharmaceuticals) buy stock in gw pharmaceuticals

: By acquiring GW, Jazz Pharmaceuticals significantly reduced its reliance on its flagship narcolepsy drug, Xyrem . The combined company now has a robust portfolio across neuroscience and oncology. If you are looking to buy stock in

To invest in the GW Pharmaceuticals portfolio today, you would need to buy shares of its parent company, . The combined company now has a robust portfolio

: The deal was designed to accelerate double-digit revenue growth. In the months following the close, Jazz reported that newly acquired products like Epidiolex contributed significantly to its total net product sales. Considerations Before Buying